Europäische Wissenschaftliche Gesellschaft




Erfolgreich durch internationale Zusammenarbeit

Oncology and immunology

Cite as: Archiv EuroMedica. 2026. 16; 1. DOI 10.35630/2026/16/Iss.1.017

Received 8 December 2025;
Accepted 17 February 2026;
Published 25 February 2026

TONSILLAR ONCOGENESIS: CHRONIC TONSILLITIS AS AN INITIATOR AND COFACTOR OF OROPHARYNGEAL CANCER

Viktor Paramonov¹ email orcid id logo, Lev Vysotskiy¹ orcid id logo,
Pavel Shchennikov¹ orcid id logo, Georgiy Potemkin¹ orcid id logo,
Aleksey Dugin¹ orcid id logo, Andrey Tantsyrev¹ orcid id logo,
Elena Subbotina¹ orcid id logo, Yuliya Mikhaylova¹ orcid id logo,
Andrey Kharzov² orcid id logo, Yuriy Emelyanov¹ orcid id logo,
Kristina Murzaeva¹ orcid id logo

¹ JSC Doctor Paramonov Clinic, Saratov, Russia
² Independent Clinical Neurologist, Saratov, Russia

download article (pdf)

  info@dr-paramonov.ru

ABSTRACT

Background

Oropharyngeal cancer represents a growing global public health problem and is predominantly characterized by a bimodal etiology associated either with exposure to tobacco and alcohol or with infection by human papillomavirus. At the same time, 15 to 25 percent of cases remain etiologically unexplained, indicating the presence of an additional pathogenetic mechanism. Chronic tonsillitis has traditionally been regarded as a background inflammatory condition without direct oncological significance; however, population based studies demonstrate a several fold increase in the risk of tonsillar cancer in such patients.

Aims

The aim of this work is a conceptual analysis of the role of chronic tonsillitis in oropharyngeal oncogenesis and the formulation of an integrative pathogenetic hypothesis explaining the contribution of chronic inflammation, microbial dysbiosis, and viral synergism to the development of both HPV positive and HPV negative cancer.

Methods

This study was conducted as a narrative review with a conceptual and analytical synthesis of epidemiological, experimental, and molecular literature relevant to chronic tonsillitis and oropharyngeal carcinogenesis. Literature selection involved a thematic and hypothesis driven selection of publications focusing on inflammation associated carcinogenesis, tonsillar microenvironmental alterations, microbial dysbiosis, immune evasion mechanisms, and interactions between bacterial inflammation and human papillomavirus. A formal systematic search protocol and quantitative data synthesis were not applied, as the primary objective was the development of an integrative pathogenetic model rather than estimation of effect sizes or prevalence.

Results

Based on analysis of the literature, a three stage model of tonsillar oncogenesis is proposed. It includes initiation of malignant transformation driven by chronic inflammation, crypt hypoxia, and genotoxic stress; promotion of tumor growth through microbial dysbiosis involving Fusobacterium nucleatum and bacterially mediated immune evasion via the Fap2 TIGIT axis; and acceleration of oncogenesis through activation of viral oncogene transcription E6 and E7 via the NF kappa B pathway.

Conclusions

Chronic tonsillitis may be regarded as a potentially significant factor in the formation of an oncogenic microenvironment of the oropharynx and as a common pathogenetic element for both HPV positive and HPV negative forms of cancer. The proposed model provides a biological explanation for the epidemiological association between chronic tonsillitis and tonsillar cancer and for the observed reduction in tonsillar cancer risk after tonsillectomy, and it underscores the need for further experimental and clinical studies.

Keywords: oropharyngeal cancer, tonsillar oncogenesis, chronic tonsillitis, human papillomavirus, inflammation associated carcinogenesis, tonsillar microbiome, Fusobacterium nucleatum, immune evasion, tonsillectomy

INTRODUCTION

Epidemiological landscape of oropharyngeal cancer

The incidence of oropharyngeal cancer (OPC) shows an alarming increase in many parts of the world [1]. Statistical data from Cancer Research UK [2] and studies by Chaturvedi et al. [3] confirm that this rise occurs against the background of declining tobacco consumption, indicating a shift in the etiological paradigm. According to projections, incidence rates continue to increase [4], reflecting an epidemic of human papillomavirus associated cancer, which now accounts for up to 80 percent of cases in developed countries [5, 6].

Etiological gap

Despite the dominance of the HPV tobacco dichotomy, this model is incomplete. It is estimated that 15 to 25 percent of oropharyngeal cancer cases are not associated with any of the established risk factors [7]. This etiological gap points to the existence of a third and largely overlooked pathway of oncogenesis, likely related to the local tissue microenvironment.

Chronic tonsillitis as a risk factor

In this context, chronic tonsillitis merits particular attention. It is not merely a recurrent infection but a persistent inflammatory condition characterized by profound structural alterations of the tonsillar crypts and the formation of stable biofilms [8]. A landmark population based study from Taiwan demonstrated a strong association, showing that patients diagnosed with chronic tonsillitis had an adjusted eightfold increased risk (OR 8.07) of subsequent tonsillar cancer [9].

Interpretative challenge

The phenomenon of reverse causality must be considered. Early stages of endophytic growing cancer may clinically mimic chronic inflammation, leading to an apparent spike in risk during the first year after diagnosis. However, even after accounting for this diagnostic bias, the persistence of a strong association in long term follow up necessitates the search for fundamental biological mechanisms.

Hypothesis formulation

We propose that chronic tonsillitis acts as an independent driver of oncogenesis through a three stage model.

  1. Initiation (inflammation). Genotoxic stress and crypt hypoxia.
  2. Promotion (dysbiosis). Immune evasion mediated by bacterial checkpoints.
  3. Acceleration (viral synergism). Bacterial activation of human papillomavirus oncogenes.

Aim and research objectives

The aim of this work is a conceptual analysis of the role of chronic tonsillitis in oropharyngeal oncogenesis and the formulation of an integrative pathogenetic hypothesis explaining the contribution of chronic inflammation, microbial dysbiosis, and viral synergism to the development of both HPV positive and HPV negative cancer.

To achieve this aim, the following research objectives were defined.

To analyze epidemiological data indicating an association between chronic tonsillitis and an increased risk of tonsillar and oropharyngeal cancer.

To examine molecular and cellular mechanisms of chronic inflammation as an initiator of genotoxic stress in tonsillar tissue.

To summarize data on the role of oropharyngeal microbial dysbiosis and bacterially mediated immune evasion in the promotion of tumor growth.

To analyze mechanisms of interaction between bacterial inflammation and human papillomavirus in the context of viral oncogene activation.

To formulate a three stage model of tonsillar oncogenesis integrating inflammatory, microbiological, and viral factors.

METHODOLOGY OF THE REVIEW

This work was conducted as a narrative literature review with analytical and conceptual synthesis of data. The aim of the review was to integrate epidemiological, experimental, and molecular studies relevant to the role of chronic tonsillitis in oropharyngeal oncogenesis and to formulate a pathogenetic hypothesis.

Literature selection was performed in a targeted manner based on thematic and conceptual relevance. Publications addressing the following areas were analyzed: epidemiology of oropharyngeal and tonsillar cancer, chronic inflammation and carcinogenesis, the oropharyngeal microbiome and dysbiosis in chronic tonsillitis, immune mechanisms of tumor evasion, and molecular aspects of the interaction between bacterial inflammation and human papillomavirus.

The review included original experimental and clinical studies, population based cohort studies, and fundamental review articles from peer reviewed international journals. Priority was given to publications providing mechanistic data and concepts relevant to the construction of a pathogenetic model. A formal systematic literature search protocol and quantitative data synthesis were not applied, as the objective of the study was not to estimate the frequency or strength of associations but to provide a conceptual explanation of potential biological mechanisms.

RESULTS

Analysis or conceptual framework

Components of the oncogenic field

Mechanism 1. Chronic inflammation as an initiator

Inflammation as a hallmark of cancer

The association between inflammation and cancer, first postulated by Rudolf Virchow in the nineteenth century [10], has now received molecular confirmation. In the seminal works of Coussens and Werb [11], as well as in contemporary reviews by Hanahan and Weinberg [12], inflammation has been codified as an enabling characteristic and as the seventh hallmark of cancer [13]. In contrast to acute inflammation, chronic tonsillitis represents a non resolving process that promotes carcinogenesis at all stages [14].

Genotoxic stress

The microenvironment of the palatine tonsils in chronic tonsillitis is characterized by increased levels of reactive oxygen and nitrogen species, predominantly produced by neutrophils [15]. These reactive molecules are associated with DNA damage in epithelial cells, including oxidative base modifications with the formation of 8 OHdG and the occurrence of DNA double strand breaks [16]. In the tonsillar epithelium under conditions of chronic inflammation, accumulation of such DNA damage has been documented, indicating tissue vulnerability in the setting of persistent oxidative stress [17, 18]. The proinflammatory cytokine milieu, particularly elevated IL 6 levels and TNF alpha signaling activity, promotes activation of cell survival pathways and reduces the elimination of genetically damaged cells through apoptosis [19].

NF kappa B and STAT3 signaling pathways

Chronic inflammation leads to the activation of key oncogenic signaling pathways.

  1. NF kappa B exhibits sustained functional activation as a result of prolonged stimulation of Toll like receptors by bacterial components [20].
  2. STAT3 represents a central oncogenic factor in head and neck cancer [21]. Its activation is mediated by interleukin 6 signaling and establishes a self sustaining signaling loop that enhances cellular proliferation and survival [22].

Mechanism 2. Microbial dysbiosis as a promoter

Microbiome in chronic tonsillitis. Anaerobic shift

Chronic tonsillitis is associated with a fundamental shift in the tonsillar microbiota. In contrast to tonsillar hypertrophy, chronic tonsillitis is characterized by the predominance of obligate anaerobes, including Fusobacterium, Prevotella, and Parvimonas. This anaerobic shift transforms the local microbiome into an oncogenic consortium [23, 24].

Immune evasion. Fap2 TIGIT axis and tumor tropism

Seminal studies on the role of Fusobacterium nucleatum in colorectal cancer by Rubinstein et al. [25] and Kostic et al. [26] have demonstrated the ability of this bacterium to directly modulate the tumor microenvironment. In the work of Han YW [27], this microorganism was described as a co conspirator of oncogenesis. Given the documented dominance of this pathogen in tonsillar crypts in chronic tonsillitis [23], these mechanisms can be extrapolated to oropharyngeal cancer.

The principal promotional mechanism in tonsillar cancer is likely the formation of an immunosuppressive niche. A central role is played by Fusobacterium nucleatum, which uses its surface protein Fap2 as a bifunctional effector.

  1. Tumor tropism. Fap2 binds to the carbohydrate antigen Gal GalNAc, which is overexpressed on the surface of malignant cells. This interaction explains the selective accumulation of Fusobacterium nucleatum within tumor tissue, functioning as a carbohydrate based homing signal [28].
  2. Immune suppression. After anchoring to tumor cells, Fap2 interacts with the inhibitory receptor TIGIT expressed on natural killer cells and cytotoxic T lymphocytes [29].

This interaction functionally disables cytotoxic immune cells, creating a protective immunological niche around transformed cells. In addition, the microbiome associated with chronic tonsillitis promotes T cell exhaustion, as evidenced by high expression of the PD 1 marker [30, 31].

Mechanism 3. Viral synergism and barrier anatomy

Crypt occlusion and hypoxia

In chronic tonsillitis, deep tonsillar crypts become occluded by massive biofilms and cellular debris [8]. This creates conditions of local hypoxia that are favorable for oncogenic anaerobic bacteria. Biofilms induce micro ulceration of the delicate reticular epithelium lining the crypts [32]. Through these micro ulcers, viruses such as human papillomavirus gain access to the basal membrane [33].

Molecular cascade of acceleration from LPS to NF kappa B to HPV

The microenvironment of chronic tonsillitis plays a decisive role in viral activation. Under normal conditions, human papillomavirus tends to suppress the activity of the cellular factor NF kappa B in order to maintain a latent phase. In chronic tonsillitis, however, a strong bacterial signal overcomes this viral suppression.

  1. Gram negative bacteria such as Fusobacterium release lipopolysaccharide.
  2. Lipopolysaccharide induces strong stimulation of the TLR4 receptor on epithelial cells [20, 34].
  3. This leads to enforced nuclear translocation of the NF kappa B transcription factor.
  4. Activated NF kappa B binds to the viral promoter region known as the long control region.
  5. This event disrupts viral latency and results in a marked increase in transcription of the viral oncogenes E6 and E7 [35, 36].

Thus, bacterial inflammation acts as an external accelerator that promotes malignant transformation.

Hypothesis formulation. Three stage model

We propose an integrative model of tonsillar oncogenesis. Table 1 summarizes the proposed three stage model of tonsillar oncogenesis integrating inflammatory, microbiological, and viral mechanisms.

Table. 1 Three stage model of tonsillar oncogenesis in chronic tonsillitis with sources cited in the article

Stage Process Key factors Main biological effect Sources
Initiation Chronic inflammation of tonsillar tissue Persistent inflammation, crypt occlusion, hypoxia, ROS and RNS DNA damage in epithelial cells, mutagenesis, reduced apoptosis Virchow 1863 [10]; Coussens and Werb 2002 [11]; Hanahan and Weinberg 2011 [12]; Colotta et al. 2009 [13]; Korniluk et al. 2017 [14]; Azad et al. [15]; Marnett 2000 [16]; Tisch et al. [17]; Greten and Grivennikov 2019 [19]
Promotion Microbial dysbiosis and immune evasion Anaerobic microbiota, Fusobacterium nucleatum, biofilms Survival and clonal expansion of transformed cells due to suppression of immune surveillance Jensen et al. 2013 [23]; Teng et al. 2023 [24]; Rubinstein et al. 2013 [25]; Kostic et al. 2013 [26]; Han 2015 [27]; Abed et al. 2016 [28]; Gur et al. 2015 [29]; Geissler et al. 2017 [30]; Guo et al. 2024 [31]; Kostic et al. 2022 [32]
Acceleration Bacterial viral synergism Lipopolysaccharide, TLR4, NF kappa B, HPV Activation of E6 and E7 oncogene transcription and acceleration of tumor growth Stanley 2012 [33]; Yang et al. 2017 [34]; Wei et al. 2014 [35]; Acay et al. 2007 [36]

DISCUSSION

Integrative model

Chronic tonsillitis functions as a common denominator for both major oropharyngeal cancer phenotypes. In HPV negative disease, it provides mutagenic pressure and local immune protection that facilitate the survival and expansion of transformed clones. In HPV positive disease, it acts as a necessary co factor, offering a plausible explanation for why only a small fraction of HPV carriers ultimately develop cancer.

Resolving the tonsillectomy paradox. Biological interpretation

Available data suggest a dichotomy, namely a slight increase in systemic risk of certain other cancers after tonsillectomy [37] alongside a substantial reduction in the risk of tonsillar cancer itself, with an odds ratio of approximately 0.24 [38].

Authors such as Chen and Fakhry [38] have attributed the reduction in carcinoma risk to patient selection bias. An alternative biological interpretation can be proposed through the lens of tumor ecology. Tonsillectomy physically removes a unique anatomical substrate, the tonsillar crypt system. By eliminating this bioreactor where biofilms accumulate under hypoxic conditions and may serve as a reservoir for HPV persistence, surgery disrupts the carcinogenic sequence at the physical level. The pronounced protective effect can therefore be interpreted as a consequence of removing both the target tissue and the associated pathological microenvironment.

The present analysis addresses the stated research objectives in a coherent manner. First, the reviewed epidemiological evidence supports a persistent association between chronic tonsillitis and increased risk of tonsillar and oropharyngeal cancer. Second, synthesis of experimental and molecular studies indicates that chronic inflammation within tonsillar tissue generates conditions of genotoxic stress and dysregulated apoptosis that are sufficient to initiate malignant transformation. Third, the assembled data support the role of microbial dysbiosis and bacterially mediated immune evasion as key mechanisms driving tumor promotion. Fourth, analysis of the interaction between bacterial inflammation and human papillomavirus provides a biologically plausible mechanism for acceleration of oncogenesis through activation of viral oncogenes. Taken together, these lines of evidence support an integrative three stage model of tonsillar oncogenesis that combines inflammatory, microbiological, and viral factors.

Limitations

This work has several limitations related to its design and scope. The article is presented as a narrative review and conceptual analysis and does not include original experimental or clinical data. Literature selection was purposeful and analytical rather than based on a formal systematic search protocol, which precludes quantitative assessment of the strength of the reported associations. The proposed mechanisms rely on extrapolation of findings from related fields of oncology, immunology, and microbiology and therefore require further experimental and clinical validation. The pathogenetic model presented does not aim to provide a definitive explanation for all cases of oropharyngeal cancer and should be regarded as a hypothesis intended to stimulate future research.

CONCLUSIONS

In accordance with the stated aim and research objectives, a conceptual analysis of data indicating the role of chronic tonsillitis in the formation of an oncogenic microenvironment of the oropharynx was performed. It is demonstrated that chronic inflammation, microbial dysbiosis, and bacterial viral synergism may jointly contribute to the initiation, promotion, and acceleration of tonsillar oncogenesis.

Based on the reviewed epidemiological and pathogenetic evidence, patients with refractory chronic tonsillitis and oropharyngeal dysbiosis should be regarded as a group at increased oncological risk. In this context, tonsillectomy may be reconsidered as a potential preventive measure against oncological disease through elimination of the anatomical substrate and pathological microenvironment that sustain carcinogenesis.

The presented conclusions are hypothetical in nature and emphasize the need for further experimental and clinical studies to validate the proposed model and to determine its practical significance.

DISCLOSURE

Authors’ contributions

Conceptualization: Viktor Paramonov, Lev Vysotskiy

Methodology: Viktor Paramonov, Lev Vysotskiy

Investigation: Viktor Paramonov, Lev Vysotskiy, Elena Subbotina

Data curation: Yuliya Mikhaylova, Andrey Kharzov, Yuriy Emelyanov, Kristina Murzaeva

Writing - review and editing: Georgiy Potemkin, Aleksey Dugin, Andrey Tantsyrev, Kristina Murzaeva

Visualization: Kristina Murzaeva

Supervision: Lev Vysotskiy, Yuliya Mikhaylova, Andrey Kharzov, Yuriy Emelyanov

All authors have read and approved the final version of the manuscript.

Funding

No external funding was received for this study.

Conflicts of Interest

The authors declare no conflicts of interest.

Artificial intelligence tools were not used for data collection, data analysis, or interpretation of the results. Their use was limited exclusively to language editing and stylistic refinement of the manuscript text.

REFERENCES

  1. SEER. Cancer Stat Facts: Oral Cavity and Pharynx Cancer. National Cancer Institute. Available from: https://seer.cancer.gov/statfacts/html/oralcav.html
  2. Cancer Research UK. Head and neck cancers risk. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/head-and-neck-cancers/risk-factors
  3. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294-4301. (Reprinted in J Clin Oncol. 2023). DOI: 10.1200/JCO.2011.36.4596
  4. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12-49. DOI: 10.3322/caac.21763
  5. Arbyn M, de Sanjosé S, Saraiya M, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191-e203. DOI: 10.1016/S2214-109X(19)30482-6
  6. Castellsagué X, Alemany L, Quer M, et al. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. J Natl Cancer Inst. 2016;108(6):djv403. DOI: 10.1093/jnci/djv403
  7. Perera M, Al-Hebshi NN, Perera I, et al. Inflammatory bacteriome and oral squamous cell carcinoma. J Dent Res. 2018;97(6):725-732. DOI: 10.1177/0022034518767118
  8. Chole RA, Faddis BT. Anatomical evidence of microbial biofilms in tonsillar tissues: a possible mechanism to explain chronicity. Arch Otolaryngol Head Neck Surg. 2003;129(6):634-636. DOI: 10.1001/archotol.129.6.634
  9. S-H Hung, L-T Kao, C-C Huang, B-C Shia, Herng-Ching Lin 4 6, et al. A Taiwanese population-based study on the association between chronic tonsillitis and tonsil cancer. Cancers (Basel). 2018;10(12):509. DOI: 10.18632/oncotarget.24262
  10. Virchow R. Die krankhaften Geschwülste. Berlin: Hirschwald; 1863.
  11. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-867. DOI: 10.1038/nature01322
  12. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674 DOI: 10.1016/j.cell.2011.02.013
  13. Colotta F, Allavena P, Sica A, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30(7):1073-1081. DOI: 10.1093/carcin/bgp127
  14. Korniluk A, Koper O, Kemona H, Dymicka-Piekarska V. From inflammation to cancer. Ir J Med Sci. 2017;186(1):57-62. DOI: 10.1007/s11845-016-1464-0
  15. Neelam Azad 1, Yon Rojanasakul, Val Vallyathan. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. DOI: 10.1080/10937400701436460
  16. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis. 2000;21(3):361-370. DOI: 10.1093/carcin/21.3.361
  17. M Tisch, S Bergenthal, H Maier. Genotoxic effects of pentachlorophenol (PCP) and lindane on human tonsillar epithelial cells. DOI: 10.1007/s00106-001-0621-5
  18. Daneste H, Sadeghzadeh A, Mokhtari M, Mohammadkhani H, Lavaee F, Moayedi J. Immunoexpression of p53 mutant-type in Iranian patients with primary and recurrence oral squamous cell carcinoma. Eur J Transl Myol. 2022 Nov 22;33(1):10847. doi: 10.4081/ejtm.2022.10847. PMID: 36413207; PMCID: PMC10141754. https://doi.org/10.4081/ejtm.2022.10847
  19. Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27-41. DOI: 10.1016/j.immuni.2019.06.025
  20. Pries R, Wollenberg B. Role of TLRs in head and neck cancer. Adv Otorhinolaryngol. 2011;70:127-139. DOI: 10.1615/critrevimmunol.v28.i3.20 PMID: 25309546
  21. Grandis JR, Drenning SD, Zeng Q, et al. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci U S A. 2000;97(8):4227-4232 DOI: 10.1073/pnas.97.8.4227
  22. Grandis JR, Drenning SD, Chakraborty A, et al. Requirement of Stat3 signaling for detection of immune effector molecules. J Clin Invest. 1998;102(7):1385-1392. DOI: 10.1172/JCI3785
  23. Jensen A, Fago-Olsen H, Sørensen CH, et al. Molecular mapping of the tonsillar crypt microbiota in health and disease. PLoS One. 2013;8(2):e56418. DOI:10.1371/journal.pone.0056418
  24. Zhi-Pan Teng, Jian-Ya Zhang, Qun Huang. Oropharyngeal microbiome in children with adenotonsillar hypertrophy and after adenotonsillectomy DOI: 10.1080/00016489.2023.2219285
  25. Rubinstein MR, Wang X, Liu W, et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14(2):195-206. DOI: 10.1016/j.chom.2013.07.012
  26. Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207-215. DOI: 10.1016/j.chom.2013.07.007
  27. Han YW. Fusobacterium nucleatum: a co-conspirator in oral and colorectal cancer. Cancer Cell. 2015;27(4):451-452. DOI: 10.1016/j.chom.2013.07.012
  28. Abed J, Emgård JE, Zamri M, et al. Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc. Cell Host Microbe. 2016;20(2):215-225. DOI: 10.1016/j.chom.2016.07.006
  29. Gur C, Ibrahim Y, Isaacson B, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to TIGIT inhibits human NK cell cytotoxicity. Immunity. 2015;42(2):344-355. DOI: 10.1016/j.immuni.2015.01.010
  30. K Geißler, R Markwart, R Pascal, et al. Functional characterization of T-cells from palatine tonsils in patients with chronic tonsillitis. PLoS One. 2017;12(8):e0183214. DOI: 10.1371/journal.pone.0183214
  31. Junlan Guo, Pengzhi Zhu , Jiangli Li, Liang Xu, Yijun Tang, Xiaohui Liu, Shengnan Guo, Jin Xia. Fusobacterium nucleatum promotes PD-L1 expression in cancer cells to evade CD8+ T cell killing in breast cancer. https://doi.org/10.1016/j.humimm.2024.111168
  32. Kostić, M.; Ivanov, M.; Babić, S.S.; Tepavčević, Z.; Radanović, O.; Soković, M.; Ćirić, A. Analysis of Tonsil Tissues from Patients Diagnosed with Chronic Tonsillitis—Microbiological Profile, Biofilm-Forming Capacity and Histology. Antibiotics 2022, 11, 1747. https://doi.org/10.3390/antibiotics11121747
  33. Stanley MA. Epithelial cell responses to infection with human papillomavirus. Clin Microbiol Rev. 2012 Apr;25(2):215-22. DOI: 10.1128/CMR.05028-11 PMID: 22491770; PMCID: PMC3346303.
  34. Yang, X., Cheng, Y. & Li, C. The role of TLRs in cervical cancer with HPV infection: a review. Sig Transduct Target Ther 2, 17055 (2017). https://doi.org/10.1038/sigtrans.2017.55 https://www.nature.com/articles/sigtrans201755
  35. Wei L, Griego AM, Chu M, Ozbun MA. Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes. Carcinogenesis. 2014 Oct;35(10):2373-81. DOI: 10.1093/carcin/bgu156 Epub 2014 Jul 26. PMID: 25064354; PMCID: PMC4178472.
  36. R R Acay , E Santos, Suzana Orsini Machado de Sousa. Correlation between c-Jun and human papillomavirus in oral premalignant and malignant lesions. DOI: 10.1016/j.oraloncology.2007.09.007
  37. Liang J, Yin L, Sjölander A, et al. Cancer risk following surgical removal of tonsils and adenoids - a population-based, sibling-controlled cohort study in Sweden. BMC Med. 2023;21(1):194. DOI: 10.1186/s12916-023-02902-x
  38. C Bai, M He, S Li, J Liu, L Zhong, F Chen, L Zhou, Y Jiang. Association between tonsillectomy and risk of oropharyngeal cancer: a systematic review DOI: 10.14639/0392-100X-N2790


back

 



Europäische Wissenschaftliche Gesellschaft